Drug Monitoring

Home
About
Help
History (1)
- Drug Monitoring
- See All Pages

"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.

Descriptor ID	D016903
MeSH Number(s)	E01.370.520.200
Concept/Terms	Drug Monitoring Drug Monitoring Monitoring, Drug Therapeutic Drug Monitoring Therapeutic Drug Monitoring Drug Monitoring, Therapeutic Monitoring, Therapeutic Drug

Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Monitoring, Physiologic [E01.370.520]
Drug Monitoring [E01.370.520.200]

Below are MeSH descriptors whose meaning is related to "Drug Monitoring".

Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.

Bar chart showing 85 publications over 26 distinct years, with a maximum of 8 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	3	4
1996	0	1	1
1997	1	1	2
1998	4	1	5
1999	1	0	1
2000	1	3	4
2001	2	0	2
2002	1	0	1
2003	1	2	3
2004	1	0	1
2005	3	1	4
2006	1	1	2
2007	0	4	4
2008	1	1	2
2010	3	2	5
2011	5	1	6
2012	4	4	8
2013	2	5	7
2014	5	2	7
2015	0	3	3
2016	1	1	2
2017	0	2	2
2019	0	2	2
2020	0	4	4
2021	0	2	2
2025	0	1	1

Below are the most recent publications written about "Drug Monitoring" by people in Profiles.

Balis FM, Rieger E, Bunin NJ, Gardiner J, Shaw LM, Olson TS, Milone MC. New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis. Cancer Chemother Pharmacol. 2025 Feb 11; 95(1):32.

View in: PubMed
Hilaire MR, Gill RV, Courtney JB, Baburina I, Gardiner J, Milone MC, Shaw LM, Meng QH, Salamone SJ. Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers. Ther Drug Monit. 2021 12 01; 43(6):766-771.

View in: PubMed
Lantigua D, Trimper J, Unal B, Camci-Unal G. A new paper-based biosensor for therapeutic drug monitoring. Lab Chip. 2021 09 07; 21(17):3289-3297.

View in: PubMed
Berg DD, Yeh RW, Mauri L, Morrow DA, Kereiakes DJ, Cutlip DE, Gao Q, Jarolim P, Michelson AD, Frelinger AL, Cange AL, Sabatine MS, O'Donoghue ML. Biomarkers of platelet activation and cardiovascular risk in the DAPT trial. J Thromb Thrombolysis. 2021 Apr; 51(3):675-681.

View in: PubMed
Lawlor M, Gupta A, Ranard LS, Madhavan MV, Li J, Eisenberger A, Parikh SA, Sethi SS, Masoumi A. Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy. Thromb Res. 2021 02; 198:79-82.

View in: PubMed
Hanania NA, Mannino DM, Criner GJ, Dransfield MT, Han MK, Jones CE, Kilbride S, Lomas DA, Martin N, Martinez FJ, Singh D, Wise RA, Halpin DMG, Lima R, Lipson DA. Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial. Chest. 2021 03; 159(3):985-995.

View in: PubMed
Yaghi S, Liberman AL, Henninger N, Grory BM, Nouh A, Scher E, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Trivedi T, Ishida K, Frontera J, Lord A, Furie K, Keyrouz S, de Havenon A, Mistry E, Leon Guerrero CR, Khan M. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation. J Stroke Cerebrovasc Dis. 2020 Jul; 29(7):104888.

View in: PubMed
Cave A, Plumptre I, Mellerio JE, Martinez AE, Kinsler VA. The adverse effect profile of acitretin in a pediatric dermatology population-Longitudinal cohort study and recommendations for monitoring. J Am Acad Dermatol. 2020 Dec; 83(6):1779-1781.

View in: PubMed
Zhao Y, Garrity D, Graves M, Linden J, St Pierre P, Ducharme P, Greene M, Vauthrin M, Weinstein R. Optimization of infusional calcium gluconate for prevention of hypocalcemic reactions during therapeutic plasma exchange. J Clin Apher. 2019 Dec; 34(6):656-660.

View in: PubMed
Okamoto LE, Shibao CA, Gamboa A, Diedrich A, Raj SR, Black BK, Robertson D, Biaggioni I. Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension. Hypertension. 2019 01; 73(1):235-241.

View in: PubMed

People

Explore

Similar Concepts

Top Journals